FiGURe 1 | impact of Hiv antigen persistence on Tfh cell differentiation in lymphoid tissues. Linear and alternative post-effector Tfh cell differentiation pathways are described. (1) Interactions between HIV particles and DC-SIGN expressing DCs could support the T helper cell differentiation toward a Tfh polarization. (2) According to the alternative post-effector differentiation pathway, HIV persistence might support Th1 and memory T cell differentiation into Tfh cells.
T (Tfr) cells are identified as the regulatory counterpart of Tfh cells. Tfr cells control T and B cell crosstalk and GC reactions.
Blood circulating Tfh cells (cTfhs) have been recently identified as a memory compartment of tissue-resident Tfh cells. Like tissueresident Tfh cells, cTfhs are endowed with the capacity to produce IL-21 and to provide B cell help (4) .
Since the last 5 years, Tfh cells have been extensively studied in the lymph nodes (LNs) and spleens of individuals with chronic HIV/SIV infection. HIV infection is associated with an altered B cell differentiation (5) and Tfh isolated from LNs of HIV-infected (HIV+) individuals provide inadequate B cell help in vitro (6) . As lymphoid tissue-resident Tfh cells are targeted by HIV/SIV early after infection, they constitute a major compartment for HIV infection, replication, and production of viral particles in LNs of viremic individuals (7) (8) (9) , even though in vivo production of viral particles by Tfh cells remains to be demonstrated. Likewise, in blood, within central memory CD4T cells, cTfh cells serve as HIV reservoir in chronic HIV-infected individuals under antiretroviral therapy (10) . Very recently, in natural HIV controllers, study of HIV infection in various CD4 T cell subsets demonstrates various mechanism of HIV persistence according to the CD4 T cell compartment (11) . LN-resident helper T cells (Tfh and non-Tfh) showed replicative virus, while clonally expanded blood CD4 T cells harbor inducible provirus (11) . However, despite their high susceptibility to HIV/SIV infection, many studies reported an accumulation of tissue-resident or cTfh populations during the chronic phases of infection (7, 8, 12, 13) . In addition, Hong et al. demonstrate that after a rapid expansion of GCs during the acute phase, slowly proliferative Tfh cells accumulate during the chronic phase of SIV infection (14) .
Various hypotheses can support the higher proportions of Tfh cell subsets in the context of chronic HIV infection: (i) Tfh cells might present high proliferative or survival capacities; (ii) antigen persistence could drive CD4 T cells toward Tfh differentiation; and (iii) regulatory cells that control the Tfh/B cell crosstalk might be defective.
Here, we propose to review recent studies based on transcriptional analysis of Tfh cell subsets and to discuss the potential consequences on GC deregulations reported in chronic HIV/SIV infection.
POTeNTiAL iMPACT OF Hiv iNFeCTiON ON Tfh CeLL DiFFeReNTiATiON
The signals involved in Tfh cell differentiation include TCR activation, costimulation, cytokines, and migration-associated molecules. However, the origin of Tfh cells is not well defined in humans: it is not clear whether Tfh fate is established at the time of DC priming or later. Here, we review the impact of HIV infection on Tfh cell differentiation, from the priming of CD4 T cells by DCs cells until their ultimate stage of differentiation corresponding to GC Tfh and circulating memory Tfh. Two distinct differentiation pathways have been described (Figure 1) . (19) . Indeed, by inducing Bcl6 early during the T cell activation, IL-6 has been shown to be critic for Tfh polarization (20) . In the context of HIV/SIV infection, several groups reported higher plasma levels of IL-6 (13, 21) . However, we and others (22) did not find any difference in the amount of secreted IL-6 between HIV-infected and -uninfected spleens upon activation (8 As DC during T cell priming, B cells also provide additional signals to Tfh cells, contributing to their helper functions and maintenance. These signals include CD40L/CD40, OX40/ OX40L, signaling lymphocyte activation molecule (SLAM) family members, and adhesion molecules that strengthen GC Tfh/ GC B cell interaction. Interaction between ICOS and ICOS ligand (ICOSL) as well as IL-21 production has been implicated in GC formation (29, 30) . PD-1/PD-1 ligand interactions also control Tfh and GC B cell differentiation (1, 31) . Murine Tfh cells also express the nutrient transporter folate R 4 (FR4) and CD73 (32) although their functional relevance for Tfh cell differentiation and B cell help has not yet been uncovered. In sum, the sequential differentiation proposes that combined interactions with DC and B cell dictate the fate of Tfh cells.
The alternative "post effector" developmental pathway proposes that Tfh-like cells may develop either from the memory CD4 T cell lineage (33, 34) or from effector T helper cell subsets (35, 36) , rather than arising from pTfh cells. It has been shown that Tfh and central memory T cells (TCM) are similar in their developmental pathway, including the requirement of Bcl6 and low levels of IL-2 signaling (37). In line with this, Tfh and TCM gene programs can co-initiate from effector Th1 cells upon increased Bcl-6 expression in response to a decrease of IL-2, resulting in a "Tfh/TCM-like" population. IL-7 signaling also acts as a negative feedback that downregulates the differentiation of Th1 into Tfh-like cells (38) . Interestingly, in spleens from HIV-infected individuals with a high proportion of Tfh cells, we reported a markedly reduced expression of the IL-7r encoding gene in all CD4 T cell populations (8) . Taken together these observations support the hypothesis that, in addition to Tfh cells, other T helper populations may contribute to B cell maturation into long-lived plasma cells. Hence, in humans, the precursors of Tfh cells might be composed of heterogeneous cell populations, which have the ability to differentiate into distinct types of Tfh cells. The latter keep some functional imprint from the parental T cell subtype. Of note, in this alternative pathway, interactions with antigen-presenting B cells are still a key event of the Tfh cell orientation thus raising the question of the impact of Tfh infection by HIV on the B cell compartments.
Germinal center Tfh cells have long been considered as the terminal stage of tissue-resident Tfh cell differentiation. Newly identified, memory Tfh cells are preferentially located in secondary lymphoid organs and bone marrow although they can recirculate in the blood. These cTfh involve several subsets that differentially support Ab secretion (4) and are related to lymphoid-tissue-resident Tfh cells by their gene expression profile, cytokine production, and functional properties (39) . Recently, adding to the CXCR5 and PD-1 canonical markers, Schultz et al. proposed that cTfh can be identified by their ability to produce IL-21, the cardinal Tfh cytokine (40) . Interestingly, activated memory B cells induce rapid re-expression of Bcl6 by memory Tfh cells (41) , reinforcing the concept that many features of Tfh cells are highly linked with those of the B cells. Thanks to their accessibility and relative high frequencies, cTfh cell dynamics and features are the focus of growing interest in the context of infection and vaccination.
THe FReQUeNCY AND FUNCTiONS OF Tfh CeLLS ARe TiGHTLY CONTROLLeD Follicular helper T cell homeostasis is critical to the induction of high affinity Ab responses that are devoid of self-reactivity. Indeed, optimal Tfh cell frequency imposes competition between B cells, thus favoring survival of high affinity B cell clones. Several cell populations maintain Tfh cell homeostasis, including regulatory T (Treg) cells, Tfr cells, CD8 regulatory cells, and plasma cells (42) . Tfr cells are identified as the main T cell subset implicated in the control of Tfh cells. They migrate into follicles and directly control GC reaction (43, 44) . Hence, many studies have demonstrated increased GC and T cell responses in the absence of Tfr (43, 45, 46) . Tfr cells co-express Bcl6 and Blimp-1 (43) that is known to negatively regulate Tfh cell differentiation pathway (47) . Indeed, Blimp-1 represses Bcl-6 and reciprocally, which might explain the lower expression of Bcl-6 in Tfr cells as compared to Tfh cells (43) . Tfr cells express CTLA-4 and produce high amounts of IL-10. They have been shown to arise from Foxp3+ precursors that highjack the Tfh differentiation pathway. However, a recent study showed that, using an appropriate vaccine adjuvant, Tfr cells can derive directly from naïve CD4 T cells (48) 7-9, 11) . Despite their high susceptibility to HIV/SIV infection, most studies reported an accumulation of tissue-resident or cTfh cell populations (7, 8, 12, 13) . Interestingly, the Tfh cell frequency positively correlates with plasma viremia levels (7, 12) , and Tfh cell accumulation is reduced in individuals that control SIV infection (53) , suggesting that the persistence of viral antigens might drive Tfh cell expansion. Accordingly, cTfh cell expansion has been recently reported in untreated individuals while the frequency of cTfh cells is restored to normal levels under cART suggesting that HIV replication also drives cTfh cell dynamics (10) . Most studies report an increase of Tfh cells among memory CD4 T cells during HIV/SIV infection, whereas others conclude with the opposite statement (9, 54) . In SIV-infected rhesus macaques, Moukambi et al. recently showed that Tfh dynamics differs from one compartment to another (peripheral blood vs. LNs or spleen) (9) . Moreover, the Tfh cell frequency varies according to (i) the stage of HIV/SIV infection (53), (ii) the severity of the disease, and (iii) the ability to develop broadly neutralizing antibodies (bNAbs) (39, 55) . In Table 1 , we summarized Tfh cell dynamics from various studies taking into account: the type of infection (HIV/SIV), the phase (acute vs. chronic), the disease progression (slow vs. fast), the immune compartment (peripheral blood vs. secondary lymphoid organs), the phenotype, and the antigen specificity of the Tfh cells. Irrespective of the immune compartment (LNs, spleen, or blood), Tfh cells are preserved in HIV/SIV controllers, displaying no Tfh cell accumulation or loss. On the contrary, Tfh cell loss is reported in fast progressors as well as in the late stages of disease.
Follicular helper T cell accumulation is reported during slow progression (SP) or chronic stage of the disease. Indeed, evidences support the pivotal role of persistent viral antigen within the GC in driving Tfh cell expansion. HIV particles are associated with FDC in tonsils and LNs from infected patients (58-60) and Cheynier et al. reported the persistence of high levels of HIV particles in GC of HIV+ spleens from untreated subjects (61) . In addition to FDC-bound virions, opsonized HIV particles interact with B cells trough CD21 membrane receptor (62, 63) . Remarkably, the accessibility of CTL to GC is reduced, thus limiting the elimination of HIV-infected cells (64) . Therefore, B cell follicles locally concentrate cell subsets implicated in HIV replication and viral production, which maintain antigen persistence and GC reactions. It appears that antigen persistence sustains ongoing GC reactions in which Tfh and GC B cell frequencies are highly correlated (8, 12, 65) . However, a limited number of fully functional Tfh cells is required for the induction of bNAbs (42) .
Another clue supporting the pivotal role of GC in driving Tfh cell expansion is that the disruption of GC organization coincides with the loss of Tfh cells and the onset of AIDS in terminal stages of SIV infection (53) . PD1/PD-L2 axis contributes to the survival of Tfh and B cells. Interestingly, the expression of PD-L2 on B cells is severely impacted in the late stages of SIV infection potentially contributing to a decreased survival of T and B cells and the termination of GC reaction (53) .
In sum, increased proportions of Tfh cells do not necessarily results in a better immune control of HIV infection, and Tfh cell proportions must be tightly regulated to allow efficient maturation and selection of B cells displaying high B cell receptor (BCR) affinity. Tfh cell functions need to be preserved to allow the production of potent bNAbs.
ALTeRATiON OF Tfh CeLL FUNCTiONS iN THe CONTeXT OF Hiv iNFeCTiON
The key role of Tfh cells is to provide B cell helper signals and to promote their differentiation into memory B cell displaying high affinity for pathogens. These signals consist of production of cytokines, such as IL-4 and IL-21, and the expression of cell surface molecules, such as OX40, ICOS, and CD40L, by Tfh cells (1) . As other groups, we analyzed the transcriptome profiles of Tfh as a mean to assess potential Tfh dysfunctions (see references in Table 2 ). Using single-cell sorting and high-throughput PCR (Fluidigm BioMark HD), we showed that expression of genes implicated in splenic Tfh and GC Tfh cell functions are deeply impacted by chronic HIV infection (8) . In this section, we intend to review the impact of HIV/SIV infection on the main signals implicated in Tfh cell functions. CD40L-CD40 (expressed by Tfh and B cell, respectively) interactions are required for the induction and maintenance of GC reaction. Blocking this molecular axis leads to GC disruption (67) . In line with this, mutation in the CD40L gene is responsible for the X-linked hyper-IgM syndrome in humans characterized by a markedly decreased serum concentrations of IgA, IgE, and IgG (68) . Our transcriptional data showed that the expression of CD40L gene is severely impacted in Tfh and GC Tfh from HIVinfected spleens (8) . Of note, CD40L down modulation has been reported in global CD4+ T cell population during the late stages of HIV infection (69) and our unpublished data.
OX40-OX40L interaction is required for B cell differentiation into plasma cells (70) . In humans, mutations in OX40 gene lead to decreased proportion of circulating memory B cells but do not impact the Ab responses (71) . HIV-infected spleens exhibit defective expression of gene encoding OX40 in Tfh and GC Tfh cells (8) . Intriguingly, we reported a reduction of memory B cell compartment in chronically HIV-infected individuals. Whether OX40 defective expression by Tfh is involved in this decrease in memory B cell should be further investigated.
During GC reactions, the expression ICOS by Tfh cells plays a major role in the process of selection of high affinity B cells. ICOS ligation leads to the overexpression of CD40L by Tfh cells that, in turn, promote the expression of ICOSL by GC B cells (72) . In mice, recent findings emphasize the crucial role of T and B cell interactions through ICOS-ICOSL and CD40L-CD40 molecular axis in the maintenance of GC reactions and the production of high affinity bone-marrow plasma cells. ICOSL has been iden- (75) . IL-4 also participates to GC B cells selection (76) . Tfh cells from SIV-infected rhesus macaques showed a marked reduction of IL-4 gene expression, and a global alteration of genes implicated in the network associated with IL-4 pathway (13) . A defective expression of IL-4 gene has also been reported in cTfh from ART-treated HIV-infected individuals (54) . We have shown a decreased secretion of IL-4 and IL-10 in splenocytes from chronically HIV-infected individuals (8) . IL-10 contributes to B cell differentiation (77) . Altered IL-10 secretion was also confirmed at the transcriptional level (8) . However, our experimental settings did not allow the discrimination of Tfh cells from the Tfr subset and IL-10 deficiencies might also be related to defective Tfr functions.
SLAMF1 is specifically required for IL-4 and IL-21 production by GC Tfh cells (78) , and SAP (SLAM-associated protein) is essential for GC reaction by stabilizing interaction between Tfh and B cells (79) . In spleens from HIV-infected donors, we also observed a defective SLAMF1 gene expression in Tfh cell subsets that might explain the low level of IL-4 production by splenocytes from HIV-infected patients (8) .
Altogether, these results indicate that HIV infection severely impacts Tfh cell functions in their capacity to provide adequate B cell help. These alterations result from both intrinsic Tfh cell defects and higher proportions of Tfh cells. Whether HIV infection alters Tfr cell functions is not clear. This issue will require further studies, especially addressing the capacities of Tfr cells to suppress Tfh cell functions or differentiation as well as B cell maturation. However, it will require identifying Tfr specific extracellular markers.
ReQUiReMeNT FOR eARLY ART iNiTiATiON AND OPTiMiZeD ACCeSSibiLiTY TO LYMPHOiD TiSSUeS HIV/SIV infection results in antigen persistence that drives CD4 T cell differentiation toward the Tfh phenotype, thus maintaining high level of Tfh cells in GC. By controlling viremia, introduction of cART allows a normalization of cTfh cell proportions while Tfh cell functions are not fully restored. In particular, in vitro production of immunoglobulin is reduced in both untreated patients and HIV-infected individuals under cART (54) . Hence, despite cART, HIV patients showing a detectable viral load (163 ± 178 HIV RNA copies/mL) did not respond to the 2009 H1N1/09 vaccine, whereas vaccine responders displayed undetectable viral loads (<40 HIV RNA copies/mL). This suggests that the persistence of viremia compromises Tfh cell functions (80) . Altogether, early control of viremia appears crucial to preserve Tfh cells functions. Additionally, while B cell compartment is not recovered in chronically infected individuals under cART, early cART initiation restores the memory B cell compartment during acute HIV infection (81) . Early cART initiation during primo infection allows a dramatic decrease of cell-associated HIV DNA and thus limits establishment of the reservoir (82, 83) . However, the poor penetration of cART into lymphoid tissues (84) could limit the efficiency of drugs even if cART was initiated early. To address these limitations, several approaches, mainly based on the molecular formulation of drugs, are actually envisaged. Injectable cART could overcome the limited access to lymphoid tissues. In the LATTE clinical trial, injection of combined cabotegravir and rilpivirine was well tolerated and efficient (85) . However, the relevance of this approach on the persistence of the HIV reservoir has not been reported yet. Very recently, the efficient elimination of latently HIV-infected cells using HIV protease-sensitive toxin nanocapsules has been reported (86) . This strategy presents the advantage to specifically eliminate HIV-infected cells without impacting healthy cells, allowing a less invasive approach. Combining new ART formulations with innovative route of administration could contribute to eradicate HIV reservoir from lymphoid organs.
In conclusion, HIV/SIV infections target Tfh cell subsets and severely affect Tfh cell frequency and functions, with dramatic impact on GC homeostasis. While limited number of fully functional Tfh cells is required for the induction of bNAbs, it is now well established that viral antigen persistence drives increased Tfh cell differentiation. To this regard, blocking HIV replication in lymphoid tissues might be a prerequisite to the induction of potent bNAbs. Preventing virus from entering lymphoid tissues should give another benefit to early ART initiation as well as the development of new strategies to optimize the access of ART to lymphoid tissues.
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